What are some interesting cases to consider for a female patient of reproductive age with potential pregnancy-related complications or gynecological conditions, such as recurrent miscarriages or polycystic ovary syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interesting Clinical Cases in Reproductive-Age Women

Case 1: Recurrent Miscarriage with Underlying Prothrombotic State

A 32-year-old woman with 4 consecutive early pregnancy losses who appears to have normal ovarian function but demonstrates hypercoagulability on thromboelastography (TEG). 1

  • This case highlights that recurrent miscarriage may result from underlying prothrombotic states rather than simple hormonal deficiencies 2
  • TEG can identify women with significantly higher maximum amplitude (MA ≥ 64 mm) and lower rates of clot lysis, with 68% sensitivity and 82% specificity for predicting subsequent miscarriage 1
  • Women with procoagulant defects who receive preconception aspirin and postconception heparin achieve pregnancy success rates exceeding 98% 1
  • The diagnostic workup should include antiphospholipid antibodies (lupus anticoagulant and anticardiolipin antibodies), thyroid function tests with TPO antibodies, and consideration of Factor V Leiden and Prothrombin G20210A mutations for second-trimester losses 1, 3

Case 2: PCOS Patient with Dramatically Elevated Miscarriage Risk

A 28-year-old woman with polycystic ovary syndrome (PCOS) diagnosed by ultrasound showing >25 follicles and ovarian volume >10 mL who becomes pregnant and faces an 11-fold increased risk of miscarriage. 4, 5

  • Women with pre-pregnancy PCOS have a subsequent miscarriage rate of 33.80% compared to 4.09% in women without PCOS (adjusted OR 11.97; 95% CI 10.27-13.95) 5
  • Metformin treatment reduces this risk by approximately 25%, with adjusted OR decreasing from 12.13 to 9.53 5
  • PCOS affects at least 7% of adult women and is the leading cause of anovulatory infertility 4
  • Ultrasound diagnosis of polycystic ovarian morphology (PCOM) alone is insufficient for PCOS diagnosis, as PCOM appears in up to one-third of reproductive-aged women 4
  • Despite the ultrasound findings, 82% of women with PCO and recurrent miscarriage who receive supportive care achieve livebirths 6, 7

Case 3: Young Woman with Pregnancy Loss and Long-Term Cardiovascular Risk

A 29-year-old woman who experiences stillbirth at 36 weeks and faces a 2-fold increased risk of cardiovascular disease-related mortality decades later. 4

  • Women with a history of stillbirth have approximately 2-fold increased risk of CVD-related mortality (95% CI 1.90-2.62) compared to women without prior history 4
  • Preeclampsia, gestational hypertension, gestational diabetes, placental abruption, and preterm birth all increase subsequent CVD and cerebrovascular morbidity and mortality 4
  • The underlying mechanism involves placental and vascular dysfunction with increased inflammation, oxidative stress, and mitochondrial dysfunction 4
  • These women require careful short- and long-term cardiovascular follow-up and management 4
  • Recurrent pre-eclampsia specifically increases stroke risk more than 2-fold and heart failure risk 4-fold 4

Case 4: Recurrent Miscarriage with Biparental Complete Hydatidiform Mole

A 26-year-old woman with 3 consecutive molar pregnancies who has diploid biparental complete hydatidiform mole (BiCHM) due to familial recurrent hydatidiform mole (FRHM) from NLRP7 gene mutations. 4

  • Unlike typical androgenetic complete hydatidiform moles (AnCHM) which are 80% from single sperm duplication and 20% from dispermic fertilization, BiCHM results from autosomal recessive FRHM 4
  • Women with FRHM caused by NLRP7 or KHDC3L mutations are unlikely to achieve normal pregnancy except through ovum donation from an unaffected individual 4
  • Women with recurrent AnCHM can have normal live births in subsequent pregnancies and benefit from conventional IVF 4
  • Genetic testing distinguishes between these conditions and guides appropriate reproductive counseling 4
  • All molar pregnancies require careful hCG monitoring for plateaued or rising levels on three and two consecutive samples respectively, indicating malignant change 4

Case 5: High-Risk Pregnancy Requiring Complex Counseling

A 35-year-old woman with WHO class III heart disease who desires pregnancy and requires comprehensive prepregnancy counseling about substantially elevated mortality risk. 4

  • Women with WHO class III or IV heart disease face substantially higher mortality risk than those with class I or II disease 4
  • Prepregnancy counseling must address risks of adverse pregnancy outcomes, short- and long-term maternal health risks, and fetal/neonatal risks 4
  • The first step is assessing the woman's reproductive life plan to determine if she desires pregnancy within the next year 4
  • If pregnancy is not desired, contraception counseling should present the most effective options first, consulting the U.S. Medical Eligibility Criteria for Contraceptive Use 4
  • Referral to maternal-fetal medicine subspecialists is appropriate for most women at increased risk 4
  • Counseling should be nondirective regarding pregnancy continuation versus termination, with expeditious timing to optimize choices 4

References

Guideline

Blood Tests for Recurrent Miscarriage Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Recurrent Miscarriage Management with Progesterone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Recurrent miscarriage: screening for polycystic ovaries and subsequent pregnancy outcome.

The Australian & New Zealand journal of obstetrics & gynaecology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.